4//SEC Filing
HARVARD BIOSCIENCE INC 4
Accession 0001209191-16-121461
$HBIOCIK 0001123494operating
Filed
May 17, 8:00 PM ET
Accepted
May 18, 9:05 PM ET
Size
10.4 KB
Accession
0001209191-16-121461
Insider Transaction Report
Form 4
UVEGES GEORGE
Director
Transactions
- Exercise/Conversion
Common Stock
2016-05-17$3.01/sh+6,589$19,833→ 91,960 total - Tax Payment
Common Stock
2016-05-17$3.23/sh−6,140$19,832→ 85,820 total - Exercise/Conversion
Stock option (right to buy)
2016-05-17−6,589→ 0 totalExercise: $3.01From: 2009-05-25Exp: 2016-05-25→ Common Stock, par value $0.01 per share (6,589 underlying)
Footnotes (4)
- [F1]Includes (a) a deferred stock award of 14,400 restricted stock units which fully vest on the earlier of (i) the date of the Issuer's next Annual Meeting of Stockholders after June 4, 2015, immediately prior to the commencement of such meeting, and (ii) June 4, 2016; (b) a deferred stock award of 13,650 restricted stock units which vest quarterly in equal installments on June 30, 2016, September 30, 2016 and December 31, 2016; and (c) 63,910 shares of common stock held by the Reporting Person.
- [F2]Represents the number of shares of common stock that the Reporting Person attested to the ownership thereof in accordance with the Issuer's Third Amended and Restated 2000 Stock Option and Incentive Plan, as amended, in connection with the payment of the option exercise price. With respect to each option exercise, the Issuer only delivered the net amount of the option shares (after reducing the option shares by the amount of shares subject to such attestation) to the Reporting Person and such attestation shares were not sold by the Reporting Person or delivered to the Issuer. Nevertheless, the SEC deems such exercise and related attestation to be a disposition of shares for purposes of Section 16(a) of the Securities Exchange Act of 1934.
- [F3]Includes (a) a deferred stock award of 14,400 restricted stock units which fully vest on the earlier of (i) the date of the Issuer's next Annual Meeting of Stockholders after June 4, 2015, immediately prior to the commencement of such meeting, and (ii) June 4, 2016; (b) a deferred stock award of 13,650 restricted stock units which vest quarterly in equal installments on June 30, 2016, September 30, 2016 and December 31, 2016; and (c) 57,770 shares of common stock held by the Reporting Person.
- [F4]Represent the exercise of stock options granted pursuant to the Issuer's 2000 Stock Option and Incentive Plan, as amended.
Documents
Issuer
HARVARD BIOSCIENCE INC
CIK 0001123494
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001123494
Filing Metadata
- Form type
- 4
- Filed
- May 17, 8:00 PM ET
- Accepted
- May 18, 9:05 PM ET
- Size
- 10.4 KB